| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |